Drawing for FIRMAPRESS

USPTO serial 79222407

FIRMAPRESS

Reviewed by CopyMark Law Group

Reg. 5527043Status 739Registered
Filing date
Status date
Registration date
Jul 31, 2018
Examiner
CROWLEY, SEAN MICHAEL
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with FIRMAPRESS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001chemical additives for use as binding agents in pharmaceuticals, cosmetics and dietary supplements; bulking agents being industrial chemicals for manufacturing pharmaceutical tablets, cosmetics tablets and dietary supplement tablets; chemical compositions and materials for use in cosmetics; chemical preparations for use in the manufacture of pharmaceuticals; chemical products for the manufacture of cosmetics; chemicals for use in manufacturing pharmaceuticals; chemicals, not being pharmaceuticals, for use in the pharmaceutical industry; diluents being industrial chemicals for diluting active ingredients when manufacturing pharmaceutical tablets, cosmetics tablets and dietary supplement tablets; excipients being industrial chemicals for bulking active ingredients when manufacturing pharmaceutical tablets, cosmetics tablets and dietary supplement tablets; fillers being industrial chemicals for bulking active ingredients when manufacturing pharmaceutical tablets, cosmetics tablets and dietary supplement tablets; industrial chemicals; preservatives for pharmaceuticalsACTIVE—
005Pharmaceuticals and pharamaceutical preparations, namely drug delivery agents in the form of powders, tablets and capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; dietary supplements; nutritional supplements; pharmaceuticals for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases, bacteria-based disorders, autoimmune diseases, autoimmune disorders, kidney diseases, kidney disorders, viruses, cancers, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cognitive disorders, diabetes, antidepressants, allergies and cardiovascular disorders; protein dietary supplements; vitamin supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 19, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 3, 2024NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jul 3, 2024C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
May 6, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 3, 2023CHLDCHANGE OF OWNER RECEIVED FROM IB—
Sep 5, 2023ES75TEAS SECTION 71 & 15 RECEIVED—
Dec 7, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 16, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 16, 2018FIMPFINAL DISPOSITION PROCESSED—
Oct 31, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 31, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 15, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 25, 2018NPUBNOTICE OF PUBLICATION—
Apr 9, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 3, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 3, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 3, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Mar 26, 2018CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 26, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 5, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 5, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 1, 2018ALIEASSIGNED TO LIE—
Jan 24, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 19, 2018RFNTREFUSAL PROCESSED BY IB—
Dec 30, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 30, 2017RFRRREFUSAL PROCESSED BY MPU—
Dec 15, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 14, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 8, 2017DOCKASSIGNED TO EXAMINER—
Dec 8, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 7, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance